Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Arginine Enhance Galactose Oxidative Capacity in Classic Galactosemia: A Pilot Study

NCT03580122 is registered in ClinicalTrials.gov with Academisch Ziekenhuis Maastricht as lead sponsor.

NCT NCT03580122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03580122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Arginine Enhance Galactose Oxidative Capacity in Classic Galactosemia: A Pilot Study
Lead sponsor
Academisch Ziekenhuis Maastricht
Phase
Phase 2
Overall status
Completed
Start date
December 5, 2017
Completion date
September 5, 2018
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

classic galactosemia